Beleodaq

(Belinostat)

Beleodaq

Drug updated on 11/9/2023

Dosage FormInjection (intravenous: 500 mg (1,000 mg/m2 over 30 minutes))
Drug ClassDeacetylase inhibitors
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of adult patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)